| Literature DB >> 32095139 |
Daniel Sakzabre1, Emmanuel Akomanin Asiamah1, Elliot Elikplim Akorsu1, Albert Abaka-Yawson1, Noble Dei Dika2, David Annor Kwasie2, Emmanuel Ativi1, Confidence Tseyiboe1, George Yiadom Osei1.
Abstract
BACKGROUND: Malaria is known to cause severe health consequences due to its marked effects and alteration on the haematological parameters of infected individuals. This study evaluated the haematological profile of adult individuals infected with the malaria parasite.Entities:
Year: 2020 PMID: 32095139 PMCID: PMC7036090 DOI: 10.1155/2020/9369758
Source DB: PubMed Journal: Adv Hematol
Haematological profile based on gender.
| Parameter | Male | Female |
|
|---|---|---|---|
| Mean ± SD | Mean ± SD | ||
| WBC (103/ | 6.43 ± 3.04 | 7 ± 7.12 | 0.5137 |
| RBC (106/ | 5.22 ± 4.50 | 4.07 ± 0.715 | 0.0017 |
| HGB (g/dL) | 12.78 ± 2.56 | 11.03 ± 2.25 | <0.001 |
| HCT (%) | 36.86 ± 7.27 | 32.72 ± 5.70 | <0.001 |
| MCV (fL) | 79.61 ± 7.42 | 86.57 ± 10.26 | 0.4754 |
| MCH (pg) | 27.31 ± 5.53 | 29.92 ± 23.29 | 0.3456 |
| MCHC (g/dL) | 34.89 ± 2.81 | 34.85 ± 11.8 | 0.9759 |
| PLT (103/ | 159.7 ± 95.82 | 169.8 ± 92.29 | 0.4446 |
| NEUT (103/ | 3.75 ± 2.25 | 4.85 ± 7.93 | 0.2499 |
| LYMPH (103/ | 2.17 ± 3.44 | 2.29 ± 6.61 | 0.8832 |
| MONO (103/ | 0.59 ± 0.34 | 0.56 ± 0.35 | 0.4705 |
| EO (103/ | 0.10 ± 0.20 | 0.081 ± 0.15 | 0.4407 |
| BASO (103/ | 0.031 ± 0.035 | 0.047 ± 0.25 | 0.5707 |
| RDW-CV (%) | 14.46 ± 3.801 | 14.29 ± 2.57 | 0.6918 |
Data are presented as mean and standard deviation (SD) with P value to determine significance. P value <0.05 is significant, and P value >0.05 is insignificant.
Haematological Profile based on type of malaria infection.
| Parameters |
|
|
|
|---|---|---|---|
| WBC (103/ | 6.73 ± 6.19 | 8.32 ± 5.47 | 0.3474 |
| RBC (106/ | 4.46 ± 2.7 | 4.04 ± 0.88 | 0.5613 |
| HGB (g/dL) | 11.59 ± 2.51 | 11.31 ± 1.98 | 0.691 |
| HCT (%) | 34.12 ± 6.45 | 32.28 ± 7.29 | 0.3056 |
| MCV (fL) | 80.27 ± 9.58 | 80.27 ± 7.74 | 0.9993 |
| MCH (pg) | 29.22 ± 20.19 | 27.32 ± 2.77 | 0.7258 |
| MCHC (g/dL) | 34.91 ± 10.2 | 34.06 ± 2.44 | 0.7547 |
| PLT (103/ | 163.60 ± 92.91 | 214.20 ± 89.67 | 0.0489 |
| NEUT (103/ | 4.56 ± 6.89 | 3.80 ± 3.02 | 0.6832 |
| LYMPH (103/ | 2.24 ± 5.96 | 2.38 ± 2.24 | 0.929 |
| MONO (103/ | 0.56 ± 0.34 | 0.63 ± 0.49 | 0.4583 |
| EO (103/ | 0.09 ± 0.17 | 0.09 ± 0.07 | 0.8829 |
| BASO (103/ | 0.04 ± 0.21 | 0.05 ± 0.06 | 0.9271 |
| RDW-CV (%) | 14.28 ± 3.02 | 15.42 ± 2.25 | 0.165 |
Data are presented as mean and standard deviation with P value to determine significance. P value <0.05 is significant, and P value >0.05 is insignificant.
Haematological profile based on parasite density.
| Parameter | <1000 | 1001–10000 | 10001–100000 | >100000 |
|
|---|---|---|---|---|---|
| Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | ||
| WBC (103/ | 6.80 ± 5.19 | 6.83 ± 8.21 | 6.69 ± 3.342 | 8.12 ± 4.56 | 0.5178 |
| RBC (106/ | 4.33 ± 0.85 | 4.31 ± 4.02 | 4.20 ± 0.8465 | 3.61 ± 1.49 | 0.784 |
| HGB (g/dL) | 11.76 ± 2.93 | 11.55 ± 2.31 | 11.43 ± 2.147 | 10.13 ± 3.12 | 0.3775 |
| HCT (%) | 34.92 ± 6.34 | 33.69 ± 6.37 | 33.59 ± 6.008 | 29.87 ± 11.8 | 0.3773 |
| MCV (fL) | 80.64 ± 6.98 | 79.79 ± 10.26 | 80.17 ± 10.45 | 86.20 ± 13.17 | 0.6183 |
| MCH (pg) | 27.51 ± 3.3 | 31.00 ± 30.11 | 27.88 ± 7.475 | 31.90 ± 11.39 | 0.9795 |
| MCHC (g/dL) | 34.31 ± 1.7 | 34.23 ± 2.08 | 36.27 ± 18.64 | 36.45 ± 7.67 | 0.5495 |
| PLT (103/ | 205.40 ± 99.55 | 162.80 ± 87.53 | 137.10 ± 85.47 | 101.80 ± 52.17 | <0.0001 |
| NEUT (103/ | 4.94 ± 8.58 | 4.44 ± 7.69 | 4.26 ± 2.053 | 3.59 ± 2.41 | 0.042 |
| LYMPH (103/ | 2.19 ± 3.94 | 2.44 ± 7.99 | 1.73 ± 1.858 | 1.15 ± 0.82 | 0.0623 |
| MONO (103/ | 0.54 ± 0.32 | 0.57 ± 0.34 | 0.59 ± 0.3975 | 0.62 ± 0.38 | 0.7888 |
| EO (103/ | 0.09 ± 0.11 | 0.10 ± 0.22 | 0.07 ± 0.129 | 0.07 ± 0.04 | 0.3813 |
| BASO (103/ | 0.02 ± 0.03 | 0.03 ± 0.04 | 0.09 ± 0.3863 | 0.03 ± 0.02 | 0.6139 |
| RDW-CV (%) | 14.63 ± 3.34 | 14.33 ± 2.71 | 14.49 ± 2.666 | 11.15 ± 5.66 | 0.8259 |
Data are presented as mean and standard deviation. P value <0.05 is significant.
Demographic characteristics of the study participants.
| Parameter |
|
| Total |
|---|---|---|---|
| Gender | |||
| Male | 64 (87.67) | 9 (12.33) | 73 (30.93) |
| Female | 142 (87.12) | 21 (12.88) | 163 (69.07) |
| Age | |||
| 18–24 | 76 (97.44) | 2 (2.56) | 78 (33.05) |
| 25–34 | 66 (94.29) | 4 (5.71) | 70 (29.66) |
| 35–44 | 29 (87.88) | 4 (12.12) | 33 (13.98) |
| 45–54 | 15 (88.24) | 2 (11.76) | 17 (7.20) |
| 55–64 | 17 (85.00) | 3 (15.00) | 20 (8.47) |
| ≥65 | 16 (88.89) | 2 (11.11) | 18 (7.63) |
Data are presented in figures and percentages.
Haematological profile of study participants.
| Parameter | Reference counts | Number ( | Percentage | |
|---|---|---|---|---|
| Haemoglobin | Normal | ≥12.5 g/dl | 105 | 44.49 |
| Anaemia | <12.5 g/dl | 131 | 55.51 | |
|
| ||||
| Leucocytes | Normal | 5.0–10.0 × 103/ | 174 | 73.73 |
| Leucocytosis | >10.0 × 103/ | 41 | 17.37 | |
| Leukopenia | <5 × 103/ | 20 | 8.47 | |
|
| ||||
| Platelets | Normal | 150–400 × 103/L | 118 | 50 |
| Thrombocytosis | >450 × 103/L | 6 | 2.54 | |
| Thrombocytopenia | <100 × 103/L | 112 | 47.46 | |
|
| ||||
| Neutrophils | Normal | 2.0–7.5 × 109/ | 139 | 58.9 |
| Neutrophilia | >7.5 × 109/ | 25 | 10.59 | |
| Neutropaenia | <2.0 × 109/ | 69 | 29.24 | |
|
| ||||
| Lymphocytes | Normal | 1.0–4.0 × 109/L | 80 | 33.9 |
| Lymphocytosis | >4.0 × 109/L | 21 | 8.9 | |
| Lymphopaenia | <1.0 × 109/L | 134 | 56.78 | |
|
| ||||
| Monocytes | Normal | 0.2–1.0 × 109/L | 162 | 68.64 |
| Monocytosis | >1.0 × 109/L | 50 | 21.19 | |
| Monocytopaenia | <0.2 × 109/L | 22 | 9.32 | |
|
| ||||
| Basophils | Normal | 0.2–0.02 × 109/L | 213 | 90.25 |
| Basophilia | >0.2 × 109/L | 8 | 3.39 | |
| Basopenia | <0.02 × 109/L | 15 | 6.36 | |
|
| ||||
| Eosinophils | Normal | 0.04–0.5 × 109/L | 121 | 51.27 |
| Eosinophilia | >0.5 × 109/L | 7 | 2.97 | |
| Eosinopaenia | <0.04 × 109/L | 108 | 45.76 | |
Data are presented in figures and percentages.